Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

KORU Medical Systems (KRMD) Gross Profit (2020 - 2025)

KORU Medical Systems (KRMD) has disclosed Gross Profit for 10 consecutive years, with $6.3 million as the latest value for Q3 2025.

  • On a quarterly basis, Gross Profit rose 20.8% to $6.3 million in Q3 2025 year-over-year; TTM through Sep 2025 was $24.3 million, a 21.14% increase, with the full-year FY2024 number at $21.3 million, up 27.67% from a year prior.
  • Gross Profit was $6.3 million for Q3 2025 at KORU Medical Systems, down from $6.5 million in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $6.5 million in Q2 2025 to a low of $3.2 million in Q2 2021.
  • A 5-year average of $4.5 million and a median of $4.3 million in 2022 define the central range for Gross Profit.
  • Biggest YoY gain for Gross Profit was 66.8% in 2021; the steepest drop was 34.62% in 2021.
  • KORU Medical Systems' Gross Profit stood at $3.8 million in 2021, then rose by 6.43% to $4.1 million in 2022, then grew by 6.2% to $4.3 million in 2023, then rose by 28.44% to $5.6 million in 2024, then increased by 12.62% to $6.3 million in 2025.
  • Per Business Quant, the three most recent readings for KRMD's Gross Profit are $6.3 million (Q3 2025), $6.5 million (Q2 2025), and $6.0 million (Q1 2025).